Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
American Tower
AMT
$78.8B
| $1.14B | 0.37% |
4,309,255
+138,089
| +3% | +$39.4M |
|
52
Illinois Tool Works
ITW
$83.9B
| $1.14B | 0.37% |
5,528,072
+291,218
| +6% | +$65.7M |
|
53
Thermo Fisher Scientific
TMO
$222B
| $1.12B | 0.37% |
1,966,320
+21,189
| +1% | +$11.6M |
|
54
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.12B | 0.37% |
30,731,257
-2,010,719
| -6% | -$73.9M |
|
55
Intel
INTC
$491B
| $1.09B | 0.36% |
20,406,962
+388,618
| +2% | +$21.1M |
|
56
RTX Corp
RTX
$302B
| $1.09B | 0.35% |
12,623,121
-71,771
| -0.6% | -$6.14M |
|
57
Nike
NKE
$62.4B
| $1.07B | 0.35% |
7,384,890
+125,928
| +2% | +$20.5M |
|
58
Schwab International Equity ETF
SCHF
$68.4B
| $1.06B | 0.35% |
54,873,428
+3,776,296
| +7% | +$75.1M |
|
59
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $1.05B | 0.34% |
38,845,802
+2,244,020
| +6% | +$61.5M |
|
60
Wells Fargo
WFC
$265B
| $1.03B | 0.34% |
22,112,534
-220,919
| -1% | -$10.2M |
|
61
Costco
COST
$422B
| $1.01B | 0.33% |
2,252,846
+71,297
| +3% | +$31.3M |
|
62
Oracle
ORCL
$435B
| $1B | 0.33% |
11,508,356
-757,028
| -6% | -$66.9M |
|
63
Danaher
DHR
$147B
| $939M | 0.31% |
3,479,979
+28,519
| +0.8% | +$7.76M |
|
64
CVS Health
CVS
$122B
| $934M | 0.31% |
11,005,268
+84,565
| +0.8% | +$7.08M |
|
65
AbbVie
ABBV
$438B
| $923M | 0.3% |
8,555,990
+34,669
| +0.4% | +$3.96M |
|
66
iShares MBS ETF
MBB
$38.9B
| $897M | 0.29% |
8,290,951
+152,386
| +2% | +$16.5M |
|
67
Starbucks
SBUX
$119B
| $894M | 0.29% |
8,102,106
+282,592
| +4% | +$33.1M |
|
68
Eli Lilly
LLY
$1.1T
| $859M | 0.28% |
3,718,099
+52,452
| +1% | +$12.9M |
|
69
Prologis
PLD
$132B
| $827M | 0.27% |
6,592,267
+105,728
| +2% | +$13.7M |
|
70
Truist Financial
TFC
$63.4B
| $819M | 0.27% |
13,966,935
+86,680
| +0.6% | +$4.84M |
|
71
Emerson Electric
EMR
$88.6B
| $817M | 0.27% |
8,671,038
+644,831
| +8% | +$64.3M |
|
72
Medtronic
MDT
$114B
| $808M | 0.26% |
6,442,879
+78,753
| +1% | +$10.2M |
|
73
Citigroup
C
$227B
| $775M | 0.25% |
11,036,402
-79,143
| -0.7% | -$5.53M |
|
74
Linde
LIN
$227B
| $746M | 0.24% |
2,542,012
+35,345
| +1% | +$10.7M |
|
75
Intuit
INTU
$91.5B
| $708M | 0.23% |
1,311,507
+18,170
| +1% | +$9.79M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.